Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy.
Olberg, H K
Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. [electronic resource] - European journal of neurology 03 2018 - 527-534 p. digital
Publication Type: Journal Article
1468-1331
10.1111/ene.13537 doi
Adult
Antibodies, Viral--blood
Female
Fingolimod Hydrochloride--pharmacology
Glatiramer Acetate--pharmacology
Humans
Immunogenicity, Vaccine--immunology
Immunologic Factors--pharmacology
Influenza Vaccines--immunology
Interferon beta-1b--pharmacology
Male
Middle Aged
Multiple Sclerosis--drug therapy
Natalizumab--pharmacology
Seasons
Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. [electronic resource] - European journal of neurology 03 2018 - 527-534 p. digital
Publication Type: Journal Article
1468-1331
10.1111/ene.13537 doi
Adult
Antibodies, Viral--blood
Female
Fingolimod Hydrochloride--pharmacology
Glatiramer Acetate--pharmacology
Humans
Immunogenicity, Vaccine--immunology
Immunologic Factors--pharmacology
Influenza Vaccines--immunology
Interferon beta-1b--pharmacology
Male
Middle Aged
Multiple Sclerosis--drug therapy
Natalizumab--pharmacology
Seasons